Immunosuppressive Therapy in Lung Transplantation.

Area of Science:

• Medicine
• Immunology
• Transplantation

Background:

• Chronic lung graft dysfunction (CLAD) is a primary cause of mortality following lung transplantation, significantly limiting long-term patient survival and graft function.
• Currently, effective therapeutic options for managing CLAD are scarce, highlighting a critical unmet need in post-transplant care.

Purpose of the Study:

• This review focuses on evaluating current maintenance immunosuppression strategies used in lung transplantation.
• It aims to present data supporting these immunosuppression protocols and discuss novel approaches, including desensitization and immunologic risk stratification.

Main Methods:

• Review of existing literature on maintenance immunosuppression protocols in lung transplantation.
• Analysis of data supporting current strategies and discussion of emerging therapeutic agents and risk stratification methods.

Main Results:

• Optimization of immunosuppression, often through drug combinations, is crucial for enhancing survival and graft function in lung transplant recipients.
• Despite advancements, CLAD remains a major challenge with limited treatment options.

Conclusions:

• Effective maintenance immunosuppression is vital for improving long-term outcomes after lung transplantation.
• Further research is essential to develop novel therapies and clarify the role of new agents in managing CLAD and improving patient survival.